Astrazeneca AZN
NYSE AZN
$156.62 -1.08 (-0.68%)
As of: Oct 2, 2026 · 1:16 PM EDT

Astrazeneca (AZN) Amortization - Intangibles (2021)

Updated

Astrazeneca's Amortization - Intangibles came in at -$54 million for Q1 2021.

Analysis

Astrazeneca (AZN) Amortization - Intangibles (2021) Analysis & Trends

For FY2020, Astrazeneca's Amortization - Intangibles was -$254 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -54.00 Mn
API Access

Astrazeneca Amortization - Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=AZN&period=max&api_key=YOUR_API_KEY